Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01600456 · ClinicalTrials.gov registry record · Phase 3
Optimizing Posttraumatic Stress Disorder Treatment: Prolonged Exposure (PE) Versus PE Plus Sertraline
A Phase 3 study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
NCT01600456 is a Phase 3 study that has completed, run by Case Western Reserve University. The registered enrollment target is 150 participants.
The verdict
NCT01600456, a Phase 3 study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
Study Summary
The specific aims of this study are: 1. To compare the effectiveness of a cognitive behavioral therapy (prolonged exposure, PE) to that of PE and medication (sertraline). 2. To compare the durability of PE gains to that of PE and sertraline at 3, 6, and 9 months post-treatment. 3. To compare those who have chosen their treatment to those who have not in terms of completion of treatment, treatment satisfaction, and short- and long-term effectiveness of the treatment. 4. To examine cost effectiveness of treatment delivery to trauma survivors with PTSD.
Interventions
- BEHAVIORAL Prolonged exposure (PE)
- OTHER PE plus Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2011-03 |
| Est. Completion | 2017-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01600456
The ClinicalTrials.gov registry entry for NCT01600456 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Western Reserve University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prolonged exposure (PE) is the first listed.
NCT01600456 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01600456 about?
NCT01600456 is a clinical study titled "Optimizing Posttraumatic Stress Disorder Treatment: Prolonged Exposure (PE) Versus PE Plus Sertraline". The specific aims of this study are: 1. To compare the effectiveness of a cognitive behavioral therapy (prolonged exposure, PE) to that of PE and medication (sertraline). 2. To compare the durability of PE gains to that of PE and sertraline at 3, 6, and 9 months post-treatment. 3. To compare those ...
What is the current status of trial NCT01600456?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2011-03. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01600456?
The interventions under investigation include: Prolonged exposure (PE) (BEHAVIORAL), PE plus Sertraline (OTHER).
Who is sponsoring clinical trial NCT01600456?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.